Back to Press Releases
SmithKline Beecham Renews License for Cybergenetics Automated Genotyping Technology
/PRNewswire/ -- SmithKline Beecham has renewed its annual nonexclusive license for Cybergenetics fully automated TrueAllele(TM) genetic analysis technology. TrueAllele software eliminates the data scoring bottleneck for microsatellite genetic data.
"Conventional manual data editing is the single greatest source of delay, error and expense in high-throughput genotyping," says Dr. Mark Perlin, CEO of Cybergenetics. "Our computer-based TrueAllele technology automates this data scoring, and can greatly accelerate genetic discovery."
TrueAllele performs automated lane tracking and automated allele calling on gel image data from Perkin Elmer/Applied Biosystems and other automated fluorescent DNA sequencers. Version 2.0 runs on the UNIX, Macintosh and PC computer platforms. SmithKline Beecham runs the TrueAllele software on Compaq 64-bit Digital UNIX workstations.
“We are pleased that SmithKline Beecham will continue to use our TrueAllele software in their advanced bioinformatics processing,'' says Dr. Perlin. “Automated data scoring eliminates one key bottleneck impeding rapid scientific discovery.'' TrueAllele's computer-based review of gels and genotypes helps scientists generate very high quality laboratory data.
Cybergenetics TrueAllele technology is protected by multiple patents. The software is used at deCODE genetics (Iceland) and various academic and government laboratories for high-throughput genotyping and gene discovery applications.
Cybergenetics is a bioinformation company based in Pittsburgh, PA that develops unique computational approaches for genetic research. Cybergenetics is committed to providing effective software systems that accelerate and simplify genetic discovery.
For more information (or to request a TrueAllele evaluation CD) please contact Cybergenetics at email@example.com, or visit the http://www.cybergenetics-inc.com web site. Cybergenetics will be demonstrating its TrueAllele software at the annual genetics meeting later this week in Denver.
© Cybergenetics 1998-2000. All rights reserved.